Australia TGA ARTG record

Dry powder inhaler

Australia TGA ARTG Registered Device · Viatris Pty Ltd · Mylan Pharmaceuticals Inc · Class I · Started January 27, 2021

Good Name: Viatris Pty Ltd - Dry powder inhaler

Device classification

Risk Class: Class I
Product Type: Procedure Pack
ARTG Category: General

Registration information

Start Date: January 27, 2021
Effective Date: January 27, 2021

Sponsor

Name: Viatris Pty Ltd

Manufacturer

Name: Mylan Pharmaceuticals Inc
Country: United States of America
Address: 150 Industrial Road, San Carlos, California, 94070

Intended purpose

The T-326 Dry Powder Inhaler is a hand-held, manually operated, passive device intended to be used for pulmonary delivery of dry powder drugs. The T-326 Inhaler is intended to be used for different drug products and by the target population specific to the drug products.

About this record

Access comprehensive regulatory information for Dry powder inhaler in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Viatris Pty Ltd, manufactured by Mylan Pharmaceuticals Inc in United States of America. The device registration started on January 27, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.